Coller Capital’s founder said in 2017 his firm would only become multi-shareholder when he has grey hair; its deal with Hunter Point this week shows the firm is moving to its next stage of ownership.
3 min read · 13 April 2023
The Hunter Point transaction means that almost all of the large secondaries firms, according to the SI 50 ranking, have either sold a stake, gone public or are part of a wider asset management platform.
2 min read · 12 April 2023
Increasingly seen as a solution to a range of GP funding needs and as an attractive source of returns, minority GP stake sales are on the rise, says Thomas Liaudet in this sponsored Q&A.
7 min read · 04 January 2023
Investor appetite for GP stakes funds has expanded rapidly, and some LPs are still treading carefully.
4 min read · 06 December 2022
The firm has seen several examples of transactions that it previously passed on being relaunched with refreshed pricing.
2 min read · 18 July 2022
Impacts from the broader economy, such as inflation, geopolitical turmoil and slower growth, have made it tougher to value assets in secondaries processes, with a wide gap between buyer and seller expectations.
3 min read · 14 July 2022
Secondaries-focused PA Capital joined forces with New York Life’s private equity affiliate GoldPoint Partners and lender Madison Capital Funding, rebranding as Apogem Capital in April.
2 min read · 30 June 2022
ICG Strategic Equity IV has beaten its target after just a year and a half in market, Secondaries Investor understands.
3 min read · 22 June 2022
Oliver Gardey and Ryan Levitt discuss market volatility, the need for specialism in secondaries and the likely drivers of LP deals in 2022.
5 min read · 17 May 2022
